Skip to main content
Clinical Trials/NCT01389245
NCT01389245CompletedNot Applicable

An Open, Prospective, Multi-center Study to Evaluate the OsseoSpeed™ TX Implant With an Early Loading Protocol in Patients With Tooth Loss in the Posterior Maxilla. A 3-years Follow-up Study.

Dentsply Sirona Implants and Consumables5 sites in 1 country42 target enrollmentStarted: June 1, 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
42
Locations
5
Primary Endpoint
Marginal Bone Level Alteration

Study Overview

Brief Summary

The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX implants in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior maxilla up to 3 years after loading. Hypothesis: Early loading of the posterior maxilla is a safe and predictable procedure.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
20 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Provision of informed consent
  • Aged 20-75 years at enrollment
  • History of edentulism in the posterior maxilla, Kennedy classes I or II, of at least four months. Last natural tooth in function is canine or first bicuspid.
  • Neighboring tooth to the planned bridge must have natural root.
  • Presence of natural teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned bridge.
  • Deemed by the investigator to have adequate bone height and a bone width of minimum 5.5 mm.
  • Deemed by the investigator as likely to present an initially stable implant situation

Exclusion Criteria

  • Unlikely to be able to comply with study procedures, as judged by the investigator
  • Earlier graft procedures in the study area
  • Current need for pre-surgical bone or soft tissue augmentation in the planned implant area.
  • Uncontrolled pathologic processes in the oral cavity
  • Known or suspected current malignancy
  • History of radiation therapy in the head and neck region
  • History of chemotherapy within 5 years prior to surgery
  • Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration
  • Uncontrolled diabetes mellitus
  • Corticosteroids or any other medication that could influence post-operative healing and/or osseointegration
  • Smoking more than 10 cigarettes/day
  • Present alcohol and/or drug abuse
  • Involvement in the planning and conduct of the study (applies to both Astra Tech staff and staff at the study site)
  • Previous enrollment in the present study.
  • Simultaneous participation in another clinical study or participation in a clinical study during the last 6 months.
  • Subjects that are unable to give informed consent

Outcomes

Primary Outcomes

Marginal Bone Level Alteration

Time Frame: Measured at implant loading and at the 3-year follow-up after implant loading.

Marginal bone level determined from radiographs and expressed as the distance from a reference point on the implant to the most coronal bone-to-implant contact on the mesial and distal aspect of the implant. Marginal bone level expressed in millimeters at the 3-year follow-up visit compared to values obtained at delivery of permanent restoration i.e. loading (baseline).

Secondary Outcomes

  • Evaluation of the Periimplant Mucosa Condition - By Assessment of PPD(Measured at the 3-year follow-up after implant loading.)
  • Number of Survived Implants(Measured at the 3-year follow-up after implant loading.)
  • Presence of Plaque(Measured at the 3-year follow-up after implant loading.)
  • Number of Stable Implants(Measured at the 3-year follow-up after implant loading.)

Investigators

Sponsor
Dentsply Sirona Implants and Consumables
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (5)

Loading locations...

Similar Trials